Title:
QUINOLINE AMINE COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF IN MEDICINE
Document Type and Number:
WIPO Patent Application WO/2023/138657
Kind Code:
A1
Abstract:
A quinoline amine compound, a preparation method therefor, and the use thereof in medicine. Specifically, the present disclosure relates to a quinoline amine compound represented by general formula (I), a preparation method therefor, a pharmaceutical composition containing the compound, and the use thereof as a therapeutic agent, in particular, the use thereof as a miRNA regulator and the use thereof in the preparation of medications for treating diseases or conditions improved by the adjustment of the level of miRNA.
Inventors:
JIA MINQIANG (CN)
YANG FANGLONG (CN)
CHEN GANG (CN)
WANG WEIMIN (CN)
HE FENG (CN)
TAO WEIKANG (CN)
YANG FANGLONG (CN)
CHEN GANG (CN)
WANG WEIMIN (CN)
HE FENG (CN)
TAO WEIKANG (CN)
Application Number:
PCT/CN2023/073152
Publication Date:
July 27, 2023
Filing Date:
January 19, 2023
Export Citation:
Assignee:
JIANGSU HENGRUI PHARMACEUTICALS CO LTD (CN)
SHANGHAI HENGRUI PHARMACEUTICAL CO LTD (CN)
SHANGHAI HENGRUI PHARMACEUTICAL CO LTD (CN)
International Classes:
C07D215/38; A61K31/47; A61K31/4709; A61K31/473; A61P1/00; A61P9/10; A61P11/00; A61P11/06; A61P17/06; A61P25/00; A61P25/16; A61P25/28; A61P29/00; A61P35/00; A61P35/02; C07D221/16; C07D401/12; C07D405/12
Domestic Patent References:
| WO2017158201A1 | 2017-09-21 | |||
| WO2020127843A1 | 2020-06-25 |
Foreign References:
| CN115433127A | 2022-12-06 | |||
| JP2017137342A | 2017-08-10 | |||
| US20090131412A1 | 2009-05-21 | |||
| CN102596935A | 2012-07-18 | |||
| CN107207463A | 2017-09-26 |
Attorney, Agent or Firm:
GE CHENG & CO., LTD. (CN)
Download PDF:
Previous Patent: BIT-SERIAL COMPUTING DEVICE AND TEST METHOD FOR EVALUATING THE SAME
Next Patent: 2019-NCOV-SPECIFIC T CELL RECEPTOR AND USE THEREOF
Next Patent: 2019-NCOV-SPECIFIC T CELL RECEPTOR AND USE THEREOF